Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Dec 15;135(12):1355–1360.

The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.

M T Schechter, W J Boyko, B Douglas, B Willoughby, A McLeod, M Maynard, K J Craib, M O'Shaughnessy
PMCID: PMC1491681  PMID: 3022904

Abstract

In an ongoing prospective study of homosexual men conducted since November 1982 in Vancouver, we identified 345 men who did not have antibody to human immunodeficiency virus (HIV) at the time of enrolment and for whom results of follow-up serologic testing were available. A total of 66 cases of seroconversion were documented among the 345 men between November 1982 and October 1985. Methods of survival data analysis that take into account the varying durations of follow-up were used to study the epidemiologic features of seroconversion in this group. The probability of seroconversion during the entire observation period was 23.1%. The seroconversion rates remained stable, at 10.5% and 10.0% during the last 2 years of the observation period. Cox regression analysis revealed the following variables to be independently associated with risk of seroconversion: frequent receptive anal intercourse, elevated number of male sexual partners in the year before enrolment, use of illicit drugs, a history of gonorrhea and age less than 30 years in November 1982. Multivariate analysis failed to reveal any role of oral sexual activity in the transmission of HIV. Oral ingestion of semen was not associated with seroconversion in either univariate or multivariate analysis. The observation that younger men were more likely to seroconvert suggests that young homosexual men were less likely than older men to modify their sexual behaviour.

Full text

PDF
1355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyko W. J., Schechter M. T., Jeffries E., Douglas B., Maynard M., O'Shaughnessy M. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Can Med Assoc J. 1985 Jul 1;133(1):28–32. [PMC free article] [PubMed] [Google Scholar]
  2. Goedert J. J., Sarngadharan M. G., Biggar R. J., Weiss S. H., Winn D. M., Grossman R. J., Greene M. H., Bodner A. J., Mann D. L., Strong D. M. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet. 1984 Sep 29;2(8405):711–716. doi: 10.1016/s0140-6736(84)92624-2. [DOI] [PubMed] [Google Scholar]
  3. Jeffries E., Willoughby B., Boyko W. J., Schechter M. T., Wiggs B., Fay S., O'Shaughnessy M. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Can Med Assoc J. 1985 Jun 15;132(12):1373–1377. [PMC free article] [PubMed] [Google Scholar]
  4. Lyman D., Winkelstein W., Ascher M., Levy J. A. Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact. JAMA. 1986 Apr 4;255(13):1703–1703. [PubMed] [Google Scholar]
  5. Melbye M., Biggar R. J., Ebbesen P., Sarngadharan M. G., Weiss S. H., Gallo R. C., Blattner W. A. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) 1984 Sep 8;289(6445):573–575. doi: 10.1136/bmj.289.6445.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nicholson J. K., McDougal J. S., Jaffe H. W., Spira T. J., Kennedy M. S., Jones B. M., Darrow W. W., Morgan M., Hubbard M. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Ann Intern Med. 1985 Jul;103(1):37–42. doi: 10.7326/0003-4819-103-1-37. [DOI] [PubMed] [Google Scholar]
  7. Schechter M. T., Boyko W. J., Douglas B., Maynard M., Willoughby B., McLeod A., Craib K. J. Can HTLV-III be transmitted orally? Lancet. 1986 Feb 15;1(8477):379–379. doi: 10.1016/s0140-6736(86)92338-x. [DOI] [PubMed] [Google Scholar]
  8. Schechter M. T., Boyko W. J., Jeffries E., Willoughby B., Nitz R., Constance P. The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy. Can Med Assoc J. 1985 Jun 1;132(11):1273–1279. [PMC free article] [PubMed] [Google Scholar]
  9. Schechter M. T., Jeffries E., Constance P., Douglas B., Fay S., Maynard M., Nitz R., Willoughby B., Boyko W. J., MacLeod A. Changes in sexual behaviour and fear of AIDS. Lancet. 1984 Jun 9;1(8389):1293–1293. doi: 10.1016/s0140-6736(84)92465-6. [DOI] [PubMed] [Google Scholar]
  10. Schüpbach J., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984 May 4;224(4648):503–505. doi: 10.1126/science.6200937. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES